Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination

Journal of Surgical Oncology
Jesus EsquivelMarcello Deraco

Abstract

Medical management with combinations of cytotoxic chemotherapy, and/or biological agents, has resulted in an unprecedented median survival >20 months in patients with Stage IV colorectal cancer. The management of disease limited to the peritoneal cavity has been controversial and at the present time, there is no published data that outlines the impact of these new therapeutic regimens when given to patients with colorectal cancer with metastatic disease confined to the peritoneum. Over the last 5 years, an increasing number of international treatment centers have published their prospective results using cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of peritoneal surface malignancies of colorectal origin and have shown that good long-term results can be achieved with a complete cytoreduction and HIPEC. However, most of the surgical data comes from Phase II studies from single institutions and there is a wide range on inclusion/exclusion criteria, drugs, temperatures and methods of delivering the heated chemotherapy. This manuscript will analyze and discuss the results of a group of health care providers trying to achieve a consensus statement in the management of this group of pat...Continue Reading

References

Jun 5, 1999·Cancer Chemotherapy and Pharmacology·P H Sugarbaker
Oct 11, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vic J VerwaalFrans A N Zoetmulder
Feb 7, 2004·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M LookP H Sugarbaker
Apr 6, 2004·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·C P CarmignaniP H Sugarbaker
Aug 18, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·O GlehenP Rat
Jan 12, 2005·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·E de BreeD D Tsiftsis
May 24, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Herbert I HurwitzFairooz Kabbinavar
Jun 1, 2005·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·C PomelD Elias
Aug 22, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tristan D YanPaul H Sugarbaker
Nov 1, 2006·Gastroentérologie Clinique Et Biologique·Dominique EliasMichel Ducreux

❮ Previous
Next ❯

Citations

Apr 6, 2012·Abdominal Imaging·Bernhard Daniel KlumppChristina Pfannenberg
Mar 13, 2012·International Journal of Colorectal Disease·Manabu ShimomuraHideki Ohdan
Jan 10, 2013·Investigational New Drugs·Mazin F Al-KasspoolesKatherine F Roby
Jun 29, 2012·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·George Z LiBryan M Clary
Apr 6, 2012·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·Umut SarpelRussell S Berman
Jun 21, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P H CashinH Mahteme
Jun 27, 2009·The Cancer Journal·Pompiliu PisoHans Juergen Schlitt
Aug 19, 2011·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·M S EdwardsD P Sykes
Jul 13, 2011·Annals of Surgical Oncology·Hatem El HalabiArmando Sardi
Feb 4, 2012·Annals of Surgical Oncology·Kiran K TuragaT Clark Gamblin
Jun 30, 2009·Annals of the Royal College of Surgeons of England·Jeffrey T LordanNariman D Karanjia
Apr 26, 2014·World Journal of Gastroenterology : WJG·Atsuya TakedaEtsuo Kunieda
May 31, 2014·World Journal of Gastroenterology : WJG·Özgür AkgülMesut Tez
May 5, 2009·World Journal of Surgery·Terence C ChuaDavid L Morris
Jan 26, 2016·Journal of Surgical Oncology·Yaniv BergerDaniel M Labow
Oct 1, 2013·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·W A JimenezV Gushchin
Jul 3, 2013·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·S RissB Moran
Jul 13, 2013·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·M A AllardD Castaing
Jan 12, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P H CashinW Graf
Dec 26, 2012·Journal of the American College of Surgeons·George Z LiBryan M Clary
Oct 2, 2012·Surgical Oncology Clinics of North America·Shigeki KusamuraMarcello Deraco
Aug 17, 2010·Critical Reviews in Oncology/hematology·S BarniF Petrelli
Dec 1, 2009·Critical Care Clinics·Sanam Ahmed, John M Oropello
Aug 22, 2009·Journal of Surgical Oncology·Aviram NissanPompiliu Piso
Jul 6, 2010·The British Journal of Surgery·C HoerskeS Merkel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.